Citation: | YANG Tong, WANG Hua-lou, CHEN Chong, ZHAO Hui-chao, XIONG Ying, JIA Jing-ya, ZHANG Mei-lin, MA Fei. Association of leukocyte telomere length in peripheral blood and the risk of mild cognitive impairment in elderly subjects:a case-control study[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(4): 409-412. doi: 10.16462/j.cnki.zhjbkz.2020.04.008 |
[1] |
Alzheimer's Association. 2016 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2016, 12(4): 459-509. DOI: 10.1016/j.jalz.2016.03.001.
|
[2] |
Wimo A. The end of the beginning of the Alzheimer's disease nightmare: a devil's advocate's view[J]. J Alzheimers Dis, 2018, 64(s1): S41-S46. DOI: 10.3233/JAD-179905.
|
[3] |
Mancioppi G, Fiorini L, Timpano SM, et al. Novel technological solutions for assessment, treatment, and assistance in mild cognitive impairment[J]. Front Neuroinform, 2019, 13(58): 1-23. DOI: 10.3389/fninf.2019.00058.
|
[4] |
Tedone E, Arosio B, Colombo F, et al. Leukocyte telomere length in Alzheimer's disease patients with a different rate of progression[J]. J Alzheimers Dis, 2015, 46(3): 761-769. DOI: 10.3233/JAD-142808.
|
[5] |
Zhan YQ, Song C, Robert K, et al. Telomere length shortening and Alzheimer disease-a mendelian randomization study[J]. JAMA Neuro, 2015, 72(10): 1202-1203. DOI: 10.1001/jamaneurol.2015.1513.
|
[6] |
Ma F, Lv X, Du Y, et al. Association of leukocyte telomere length with mild cognitive impairment and Alzheimer's disease: role of folate and homocysteine[J]. Dement Geriatr Cogn Disord, 2019, 1-12. DOI: 10.1159/000501958.
|
[7] |
Scarabino D, Broggio E, Gambina G, et al. Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients[J]. Exp Gerontol, 2017, 98: 143-147. DOI: 10.1016/j.exger.2017.08.025.
|
[8] |
Lau H, Mat AF, Rajab NF, et al. Identification of neuroprotective factors associated with successful ageing and risk of cognitive impairment among Malaysia older adults[J]. Curr Gerontol Geriatr Res, 2017, 2017(7): 1-7. DOI: 10.1155/2017/4218756.
|
[9] |
Roberts RO, Boardman LA, Cha RH, et al. Short and long telomeres increase risk of amnestic mild cognitive impairment[J]. Mech Ageing Dev, 2014, 1(141-142): 64-69. DOI: 10.1016/j.mad.2014.10.002.
|
[10] |
Leigh H. Diagnostic and statistical manual of mental disorders(DSM)[M]. Encyclopedia of clinical neuropsychology cham; Springer International Publishing, 2018: 1-4. DOI: 10.1007/978-3-319-56782-2_9129-1.
|
[11] |
韩睿婕.病例对照分析法样本容量及基因外显率参数的估计方法[D].杨凌: 西北农林科技大学, 2009.
Han RJ. Estimating sample size and penetrance parameters for case-control design of candidate-gene associations[D]. Yangling: Northwest A & F University, 2009.
|
[12] |
Cawthon RM. Telomere measurement by quantitative PCR[J]. Nucleic acids research, 2002, 30(10): e47. DOI: 10.1093/nar/30.10.e47.
|
[13] |
Innes KE, Selfe TK, Brundage K, et al. Effects of meditation and music-listening on blood biomarkers of cellular aging and Alzheimer's disease in adults with subjective cognitive decline: an exploratory randomized clinical trial[J]. J Alzheimers Dis, 2018, 66(3): 947-970. DOI: 10.3233/JAD-180164.
|
[14] |
Sindi S, Ngandu T, Hovatta I, et al. Baseline telomere length and effects of a multidomain lifestyle intervention on cognition: the FINGER randomized controlled trial[J]. J Alzheimers Dis, 2017, 59(4): 1459-1470. DOI: 10.3233/JAD-170123.
|
[15] |
Tonnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer's disease[J]. J Alzheimers Dis, 2017, 57(4): 1105-1121. DOI: 10.3233/JAD-161088.
|
[16] |
Mota SI, Costa RO, Ferreira IL, et al. Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease[J]. Biochim Biophys Acta, 2015, 1852(7): 1428-1441. DOI: 10.1016/j.bbadis.2015.03.015.
|
[17] |
Ahmed W, Lingner J. Impact of oxidative stress on telomere biology[J]. Differentiation, 2018, 99(21-27). DOI: 10.1016/j.diff.2017.12.002.
|
[18] |
Cai Z, Yan LJ, Ratka A. Telomere shortening and Alzheimer's disease[J]. Neuromolecular Med, 2013, 15(1): 25-48. DOI: 10.1007/s12017-012-8207-9.
|